{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:17:57Z","timestamp":1774685877469,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":1766,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001027","name":"Department of Health and Ageing, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1017\/s1041610219002011","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T02:38:56Z","timestamp":1579747136000},"page":"335-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project"],"prefix":"10.1016","volume":"32","author":[{"given":"Fleur","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-0463","authenticated-orcid":false,"given":"Monica","family":"Cations","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Jessop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Chenoweth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Shell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perminder","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hilmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Draper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Brodaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610219002011_bb0010","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/archinte.166.20.2182","article-title":"Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review","volume":"166","author":"Ayalon","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1017\/S1041610219002011_bb0015","author":"Banerjee"},{"key":"10.1017\/S1041610219002011_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jamda.2018.05.002","article-title":"Antipsychotic deprescription for older adults in long-term care: the HALT study","volume":"19","author":"Brodaty","year":"2018","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S1041610219002011_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7148515","article-title":"Critical contextual elements in facilitating and achieving success with a person-centred care intervention to support antipsychotic deprescribing for older people in long-term care","volume":"2018","author":"Chenoweth","year":"2018","journal-title":"BioMed Research International"},{"key":"10.1017\/S1041610219002011_bb0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.healthpol.2015.02.014","article-title":"A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents","volume":"119","author":"Chiu","year":"2015","journal-title":"Health Policy"},{"key":"10.1017\/S1041610219002011_bb0035","doi-asserted-by":"crossref","first-page":"M77","DOI":"10.1093\/geronj\/44.3.M77","article-title":"A description of agitation in a nursing home","volume":"44","author":"Cohen-Mansfield","year":"1989","journal-title":"The Journals of Gerontology"},{"key":"10.1017\/S1041610219002011_bb0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jamda.2010.10.004","article-title":"Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers","volume":"13","author":"Corneg\u00e9-Blokland","year":"2012","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S1041610219002011_bb0045","first-page":"100129","article-title":"Patterns of antipsychotic use among community-dwelling elderly patients with dementia: impact of regulatory warnings","volume":"5","author":"Craig","year":"2016","journal-title":"Medical Safety & Global Health"},{"key":"10.1017\/S1041610219002011_bb0050","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"3","key":"10.1017\/S1041610219002011_bb0055","first-page":"CD007726","article-title":"Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia","author":"Declercq","year":"2013","journal-title":"Cochrane Database System Review"},{"key":"10.1017\/S1041610219002011_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S1041610217002344","article-title":"An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia","volume":"30","author":"Dyer","year":"2017","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219002011_bb0065","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.9778\/cmajo.20150095","article-title":"Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study","volume":"4","author":"Foster","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1017\/S1041610219002011_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2050-6511-14-10","article-title":"Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Pharmacology and Toxicology"},{"key":"10.1017\/S1041610219002011_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40266-018-0623-6","article-title":"Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia","volume":"36","author":"Harrison","year":"2018","journal-title":"Drugs & Aging"},{"key":"10.1017\/S1041610219002011_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/geronj\/42.4.395","article-title":"Standardization and validation of the multidimensional observation scale for elderly subjects (MOSES)","volume":"42","author":"Helmes","year":"1987","journal-title":"The Journals of Gerontology"},{"key":"10.1017\/S1041610219002011_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12877-017-0440-5","article-title":"Persistent use of psychotropic drugs in nursing home residents in Norway","volume":"17","author":"Helvik","year":"2017","journal-title":"BMC Geriatrics"},{"key":"10.1017\/S1041610219002011_bb0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-150280","article-title":"Psychotropic drug prescription in patients with dementia: nursing home residents versus patients living at home","volume":"49","author":"Jacquin-Piques","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610219002011_bb0095","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1017\/S1041610217000084","article-title":"Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia","volume":"29","author":"Jessop","year":"2017","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219002011_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S0033291700033377","article-title":"The psychogeriatric assessment scales: a multi-dimensional alternative to categorical diagnoses of dementia and depression in the elderly","volume":"25","author":"Jorm","year":"1995","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610219002011_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/pharmacy7030100","article-title":"Reduction in use of risperidone for dementia in Australia following changed guidelines","volume":"7","author":"Kalisch Ellett","year":"2019","journal-title":"Pharmacy"},{"key":"10.1017\/S1041610219002011_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JAD-160671","article-title":"Risk of mortality associated with antipsychotic monotherapy and polypharmacy among community-dwelling persons with Alzheimer\u2019s disease","volume":"56","author":"Koponen","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610219002011_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5694\/mja15.01339","article-title":"Clinical practice guidelines for dementia in Australia","volume":"204","author":"Laver","year":"2016","journal-title":"The Medical Journal of Australia"},{"key":"10.1017\/S1041610219002011_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"The Gerontologist"},{"key":"10.1017\/S1041610219002011_bb0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: the minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophrenia Bulletin"},{"key":"10.1017\/S1041610219002011_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/gps.4037","article-title":"Grouping of behavioural and psychological symptoms of dementia","volume":"29","author":"Linde","year":"2014","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0135","first-page":"61","article-title":"Functional evaluation: the Barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Maryland State Medical Journal"},{"key":"10.1017\/S1041610219002011_bb0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the centers for medicare & medicaid services\u2019 national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Internal Medicine"},{"key":"10.1017\/S1041610219002011_bb0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eurpsy.2016.11.013","article-title":"Antipsychotic treatment effects on cardiovascular, cancer, infection, and intentional self-harm as cause of death in patients with Alzheimer\u2019s dementia","volume":"42","author":"Nielsen","year":"2017","journal-title":"European Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/acps.12614","article-title":"Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer\u2019s dementia","volume":"134","author":"Nielsen","year":"2016","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610219002011_bb0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/WAD.0b013e31818207d0","article-title":"Alzheimer special care units compared with traditional nursing home for dementia care: are there differences at admission and in clinical outcomes?","volume":"22","author":"Nobili","year":"2008","journal-title":"Alzheimer Disease & Associated Disorders"},{"key":"10.1017\/S1041610219002011_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/YIC.0b013e328323aaf0","article-title":"Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units","volume":"24","author":"Nobili","year":"2009","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1017\/S1041610219002011_bb0170","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1017\/S1041610210000165","article-title":"Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia","volume":"22","author":"O\u2019Connor","year":"2010","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219002011_bb0175","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bcp.12955","article-title":"Prescribing pattern of antipsychotic drugs during the years 1996\u20132010: a population-based database study in Europe with a focus on torsadogenic drugs","volume":"82","author":"Oteri","year":"2016","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1017\/S1041610219002011_bb0180","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.arr.2013.05.002","article-title":"Interventions targeting pain or behaviour in dementia: a systematic review","volume":"12","author":"Pieper","year":"2013","journal-title":"Ageing Research Reviews"},{"key":"10.1017\/S1041610219002011_bb0185","doi-asserted-by":"crossref","first-page":"P164","DOI":"10.1093\/geronj\/43.6.P164","article-title":"Psychometric assessment of the Multidimensional Observation Scale for Elderly Subjects (MOSES)","volume":"43","author":"Pruchno","year":"1988","journal-title":"The Journals of Gerontology"},{"key":"10.1017\/S1041610219002011_bb0190","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/00019442-200511000-00010","article-title":"Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance","volume":"13","author":"Rabinowitz","year":"2005","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0195","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1177\/1471301217746769","article-title":"Use of antipsychotics and benzodiazepines for dementia: time for action? What will be required before global de-prescribing?","volume":"18","author":"Ralph","year":"2019","journal-title":"Dementia"},{"key":"10.1017\/S1041610219002011_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/gps.2094","article-title":"Substitute consent for nursing home residents prescribed psychotropic medication","volume":"24","author":"Rendina","year":"2009","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/1060028013520196","article-title":"Psychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice","volume":"48","author":"Rojas-Fernandez","year":"2014","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1017\/S1041610219002011_bb0210","series-title":"Professional Practice Guideline 10: Antipsychotic Medications as a Treatment of Behavioural and Psychological Symptoms of Dementia","author":"Royal Australian and New Zealand College of Psychiatrists","year":"2016"},{"key":"10.1017\/S1041610219002011_bb0215","series-title":"Interim Report: Neglect","author":"Royal Commission into Aged Care Quality and Safety","year":"2019"},{"key":"10.1017\/S1041610219002011_bb0220","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1017\/S1041610216000715","article-title":"A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes?","volume":"28","author":"Sawan","year":"2016","journal-title":"International Psychogeriatric"},{"key":"10.1017\/S1041610219002011_bb0225","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/JGP.0b013e318167ae76","article-title":"The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes\u2014a 12-month follow-up study","volume":"16","author":"Selb\u00e6k","year":"2008","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0230","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1017\/S1041610211000445","article-title":"Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries","volume":"23","author":"Snowdon","year":"2011","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219002011_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1041610204000043","article-title":"The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale","volume":"16","author":"Storey","year":"2004","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219002011_bb0240","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s40263-016-0366-z","article-title":"The effect of safety warnings on antipsychotic drug prescribing in elderly persons with dementia in the United Kingdom and Italy: a population-based study","volume":"30","author":"Sultana","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1017\/S1041610219002011_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009882","article-title":"Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period","volume":"6","author":"Szczepura","year":"2016","journal-title":"BMJ Open"},{"key":"10.1017\/S1041610219002011_bb0250","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.euroneuro.2014.10.004","article-title":"High prevalence of psychotropic drug use among persons with and without Alzheimer\u2019s disease in Finnish nationwide cohort","volume":"24","author":"Taipale","year":"2014","journal-title":"European Neuropsychopharmacology"},{"key":"10.1017\/S1041610219002011_bb0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2040622316658463","article-title":"Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses","volume":"7","author":"Tampi","year":"2016","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"10.1017\/S1041610219002011_bb0260","first-page":"1","article-title":"Risperidone and risk of cerebrovascular adverse events in dementia patients","volume":"6","author":"Therapeutic Goods Administration","year":"2015","journal-title":"Medicines Safety Update"},{"key":"10.1017\/S1041610219002011_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12877-015-0048-6","article-title":"Association between pain, neuropsychiatric symptoms, and physical function in dementia: a systematic review and meta-analysis","volume":"15","author":"van Dalen-Kok","year":"2015","journal-title":"BMC Geriatrics"},{"key":"10.1017\/S1041610219002011_bb0270","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-2012-120913","article-title":"Apathy syndrome in Alzheimer\u2019s disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors","volume":"33","author":"Vilalta-Franch","year":"2013","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610219002011_bb0275","article-title":"The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: a literature review","author":"Westaway","year":"2018","journal-title":"Dementia"},{"key":"10.1017\/S1041610219002011_bb0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0004867418758919","article-title":"More action needed: psychotropic prescribing in Australian residential aged care","volume":"53","author":"Westbury","year":"2019","journal-title":"Australia and New Zealand Journal of Psychiatry"},{"key":"10.1017\/S1041610219002011_bb0285","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1017\/S1041610211000421","article-title":"A 12-month follow-up study of \u201cRedUSe\u201d: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes","volume":"23","author":"Westbury","year":"2011","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219002011_bb0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00406-016-0723-4","article-title":"Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trials","volume":"267","author":"Wolf","year":"2016","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1017\/S1041610219002011_bb0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/ageing\/afn135","article-title":"Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study","volume":"37","author":"Wood-Mitchell","year":"2008","journal-title":"Age and Ageing"},{"key":"10.1017\/S1041610219002011_bb0300","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/jgs.15223","article-title":"Where are antipsychotics prescribed in nursing homes initiated?","volume":"66","author":"Zhang","year":"2018","journal-title":"Journal of the American Geriatrics Society"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610219002011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:36:01Z","timestamp":1762353361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224024852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1041610224024852"],"URL":"https:\/\/doi.org\/10.1017\/s1041610219002011","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610219002011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}